The government has reached an out-of-court settlement with Sir Olly Robbins, the former permanent secretary at the Foreign, Commonwealth and Development Office, following his legal challenge to his dismissal during the controversy over Peter Mandelson’s security vetting.
The agreement was announced on Friday 16 October 2026 by the FDA, the union representing senior civil servants. A government spokesperson separately confirmed that a settlement had been reached, but declined to comment on its terms.
Legal challenge ends without a court ruling
Robbins was removed from his senior Foreign Office position in April by then-prime minister Sir Keir Starmer after questions arose about how Mandelson had received security clearance to serve as British ambassador to the United States despite concerns raised during the vetting process.
In July, Robbins sought a judicial review of his dismissal. His case challenged both the fairness of the process and the legal basis on which the decision was made. Those were arguments advanced by Robbins and his representatives, rather than findings made by a court.
Friday’s settlement brings the dispute towards a conclusion without a final judicial determination that the dismissal was unlawful. The government has not publicly admitted liability.
Government confirms agreement
In a statement reported by Civil Service World, a government spokesperson acknowledged Robbins’ distinguished public-service career spanning three decades and confirmed that an agreement had been reached following his dismissal. The spokesperson said the government would not comment further on personnel matters.
Robbins thanked former colleagues and the FDA for their support and said he was looking forward to the next chapter of his life.
FDA general secretary Dave Penman criticised the handling of the affair, alleging that Robbins had been made a scapegoat for political decisions. Penman also called for clarification of ministers’ involvement in the security-vetting process. These are the union’s criticisms, not conclusions established by the settlement.
How much will the settlement cost?
The government and FDA have not disclosed the financial terms. The Guardian and Financial Times have reported that the settlement is believed to be in six figures, but that figure has not been officially confirmed. It would therefore be premature to state a precise cost to the taxpayer.
Questions remain over ambassadorial appointments
The dispute arose from scrutiny of Mandelson’s appointment as ambassador to Washington and the distinction between political appointment decisions and security clearance procedures. The House of Commons Foreign Affairs Committee has examined the appointment and called for stronger safeguards around future political diplomatic appointments.
The settlement resolves a dispute between the government and a former senior official, but it does not itself determine whether the original vetting arrangements were adequate or settle wider questions about ministerial accountability. Those matters remain distinct from the terms of the agreement.